The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Barker Sam L since 2017.
This trader's CIK number is 1226877.
At the time of last reporting, Barker Sam L was the Director of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX).
Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | LXRX | 0 | $0 | 0 | $0 | 89,312 | $0 |
| 2025 | LXRX | 0 | $0 | 0 | $0 | 36,810 | $0 |
| 2024 | LXRX | 0 | $0 | 0 | $0 | 8,032 | $0 |
| 2023 | LXRX | 0 | $0 | 0 | $0 | 9,302 | $0 |
| 2022 | LXRX | 0 | $0 | 0 | $0 | 4,024 | $0 |
| 2020 | LXRX | 0 | $0 | 0 | $0 | 3,466 | $0 |
| 2019 | LXRX | 24,000 | $28,200 | 0 | $0 | 0 | $0 |
| 2017 | LXRX | 1,000 | $12,500 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CYCC | 1,000 | $5,000 | 12 | $42 | 0 | $0 |
1. Lexicon Pharmaceuticals, Inc. (LXRX)
2. Bio Green Med Solution, Inc. (CYCC)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-03 | LXRX | Option Ex | 89,312 | .00 | 0 |
| 2025-05-13 | LXRX | Option Ex | 36,810 | .00 | 0 |
| 2024-04-28 | LXRX | Option Ex | 8,032 | .00 | 0 |
| 2023-05-21 | LXRX | Option Ex | 9,302 | .00 | 0 |
| 2022-04-30 | LXRX | Option Ex | 4,024 | .00 | 0 |
| 2020-04-26 | LXRX | Option Ex | 3,466 | .00 | 0 |
| 2019-08-02 | LXRX | Buy | 24,000 | 1.18 | 28,200 |
| 2017-09-15 | LXRX | Buy | 1,000 | 12.50 | 12,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-30 | CYCC | Sale | 12 | 3.57 | 42 |
| 2021-08-24 | CYCC | Buy | 1,000 | 5.00 | 5,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barker Sam L (Director of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.